Management of advanced renal cancer

被引：11
作者：
Atkins, M
机构：
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA
[2] Dana Farber Harvard Canc Ctr, Boston, MA USA
来源：
KIDNEY INTERNATIONAL | 2005年 / 67卷 / 05期
关键词：
cytokine-based immunotherapy; von Hippel-Lindau disease; cytoreductive nephrectomy; interleukin-2; carbonic anhydrase IX; bevacizumab; erlotinib; sorafenib;
D O I：
10.1111/j.1523-1755.2005.00309.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2069 / 2082
页数：14
相关论文
共 62 条
[1]  
[Anonymous], P AM SOC CLIN ONCOL
[2]  
[Anonymous], **NON-TRADITIONAL**
[3]   Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma [J].
Atkins, MB ;
Hidalgo, M ;
Stadler, WM ;
Logan, TF ;
Dutcher, JP ;
Hudes, GR ;
Park, Y ;
Lion, SH ;
Marshall, B ;
Boni, JP ;
Dukart, G ;
Sherman, ML .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :909-918
[4]  
ATKINS MB, 2003, ORTHO BIOTECH ONCOLO, V72, P87
[5]  
Bui MHT, 2003, CLIN CANCER RES, V9, P802
[6]  
COLE B, 2003, P AN M AM SOC CLIN, V22, P387
[7]   Mutations of the BRAF gene in human cancer [J].
Davies, H ;
Bignell, GR ;
Cox, C ;
Stephens, P ;
Edkins, S ;
Clegg, S ;
Teague, J ;
Woffendin, H ;
Garnett, MJ ;
Bottomley, W ;
Davis, N ;
Dicks, N ;
Ewing, R ;
Floyd, Y ;
Gray, K ;
Hall, S ;
Hawes, R ;
Hughes, J ;
Kosmidou, V ;
Menzies, A ;
Mould, C ;
Parker, A ;
Stevens, C ;
Watt, S ;
Hooper, S ;
Wilson, R ;
Jayatilake, H ;
Gusterson, BA ;
Cooper, C ;
Shipley, J ;
Hargrave, D ;
Pritchard-Jones, K ;
Maitland, N ;
Chenevix-Trench, G ;
Riggins, GJ ;
Bigner, DD ;
Palmieri, G ;
Cossu, A ;
Flanagan, A ;
Nicholson, A ;
Ho, JWC ;
Leung, SY ;
Yuen, ST ;
Weber, BL ;
Siegler, HF ;
Darrow, TL ;
Paterson, H ;
Marais, R ;
Marshall, CJ ;
Wooster, R .
NATURE, 2002, 417 (6892) :949-954
[8]  
Dutcher JP, 1997, CANCER J, V3, pS73
[9]  
Dutcher JP, 1997, CANCER J SCI AM, V3, P157
[10]  
Dutcher JP, 2000, CLIN CANCER RES, V6, P3442
1234567